6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives

6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives

Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JOEL R. WALKER, HELENE DECORNEZ, FERYAN AHMED, MAHENDER GURRAM, RAYMOND HUNTLEY, ZOHREH SAJJADI-HASHEMI, YUSUKE NAKAMURA, YO MATSUO, SHOJI HISADA, WENGE CUI, ROBERT B. KARGBO, DAVID M. JENKINS, POLIVINA JOLICIA F. GAUUAN
Format: Patent
Sprache:eng ; heb
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JOEL R. WALKER
HELENE DECORNEZ
FERYAN AHMED
MAHENDER GURRAM
RAYMOND HUNTLEY
ZOHREH SAJJADI-HASHEMI
YUSUKE NAKAMURA
YO MATSUO
SHOJI HISADA
WENGE CUI
ROBERT B. KARGBO
DAVID M. JENKINS
POLIVINA JOLICIA F. GAUUAN
description Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL222080B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL222080B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL222080B3</originalsourceid><addsrcrecordid>eNrjZDA2003Mya7M0S3JyEzNy4820jHWTY4tLM3My8_JzNM10TDN0NTNz0tVSEktyixLLMksSy3mYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxnj5GRkYGFgZOxgQVAABmsSna</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives</title><source>esp@cenet</source><creator>JOEL R. WALKER ; HELENE DECORNEZ ; FERYAN AHMED ; MAHENDER GURRAM ; RAYMOND HUNTLEY ; ZOHREH SAJJADI-HASHEMI ; YUSUKE NAKAMURA ; YO MATSUO ; SHOJI HISADA ; WENGE CUI ; ROBERT B. KARGBO ; DAVID M. JENKINS ; POLIVINA JOLICIA F. GAUUAN</creator><creatorcontrib>JOEL R. WALKER ; HELENE DECORNEZ ; FERYAN AHMED ; MAHENDER GURRAM ; RAYMOND HUNTLEY ; ZOHREH SAJJADI-HASHEMI ; YUSUKE NAKAMURA ; YO MATSUO ; SHOJI HISADA ; WENGE CUI ; ROBERT B. KARGBO ; DAVID M. JENKINS ; POLIVINA JOLICIA F. GAUUAN</creatorcontrib><description>Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.</description><language>eng ; heb</language><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180531&amp;DB=EPODOC&amp;CC=IL&amp;NR=222080B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180531&amp;DB=EPODOC&amp;CC=IL&amp;NR=222080B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JOEL R. WALKER</creatorcontrib><creatorcontrib>HELENE DECORNEZ</creatorcontrib><creatorcontrib>FERYAN AHMED</creatorcontrib><creatorcontrib>MAHENDER GURRAM</creatorcontrib><creatorcontrib>RAYMOND HUNTLEY</creatorcontrib><creatorcontrib>ZOHREH SAJJADI-HASHEMI</creatorcontrib><creatorcontrib>YUSUKE NAKAMURA</creatorcontrib><creatorcontrib>YO MATSUO</creatorcontrib><creatorcontrib>SHOJI HISADA</creatorcontrib><creatorcontrib>WENGE CUI</creatorcontrib><creatorcontrib>ROBERT B. KARGBO</creatorcontrib><creatorcontrib>DAVID M. JENKINS</creatorcontrib><creatorcontrib>POLIVINA JOLICIA F. GAUUAN</creatorcontrib><title>6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives</title><description>Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDA2003Mya7M0S3JyEzNy4820jHWTY4tLM3My8_JzNM10TDN0NTNz0tVSEktyixLLMksSy3mYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxnj5GRkYGFgZOxgQVAABmsSna</recordid><startdate>20180531</startdate><enddate>20180531</enddate><creator>JOEL R. WALKER</creator><creator>HELENE DECORNEZ</creator><creator>FERYAN AHMED</creator><creator>MAHENDER GURRAM</creator><creator>RAYMOND HUNTLEY</creator><creator>ZOHREH SAJJADI-HASHEMI</creator><creator>YUSUKE NAKAMURA</creator><creator>YO MATSUO</creator><creator>SHOJI HISADA</creator><creator>WENGE CUI</creator><creator>ROBERT B. KARGBO</creator><creator>DAVID M. JENKINS</creator><creator>POLIVINA JOLICIA F. GAUUAN</creator><scope>EVB</scope></search><sort><creationdate>20180531</creationdate><title>6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives</title><author>JOEL R. WALKER ; HELENE DECORNEZ ; FERYAN AHMED ; MAHENDER GURRAM ; RAYMOND HUNTLEY ; ZOHREH SAJJADI-HASHEMI ; YUSUKE NAKAMURA ; YO MATSUO ; SHOJI HISADA ; WENGE CUI ; ROBERT B. KARGBO ; DAVID M. JENKINS ; POLIVINA JOLICIA F. GAUUAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL222080B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2018</creationdate><toplevel>online_resources</toplevel><creatorcontrib>JOEL R. WALKER</creatorcontrib><creatorcontrib>HELENE DECORNEZ</creatorcontrib><creatorcontrib>FERYAN AHMED</creatorcontrib><creatorcontrib>MAHENDER GURRAM</creatorcontrib><creatorcontrib>RAYMOND HUNTLEY</creatorcontrib><creatorcontrib>ZOHREH SAJJADI-HASHEMI</creatorcontrib><creatorcontrib>YUSUKE NAKAMURA</creatorcontrib><creatorcontrib>YO MATSUO</creatorcontrib><creatorcontrib>SHOJI HISADA</creatorcontrib><creatorcontrib>WENGE CUI</creatorcontrib><creatorcontrib>ROBERT B. KARGBO</creatorcontrib><creatorcontrib>DAVID M. JENKINS</creatorcontrib><creatorcontrib>POLIVINA JOLICIA F. GAUUAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JOEL R. WALKER</au><au>HELENE DECORNEZ</au><au>FERYAN AHMED</au><au>MAHENDER GURRAM</au><au>RAYMOND HUNTLEY</au><au>ZOHREH SAJJADI-HASHEMI</au><au>YUSUKE NAKAMURA</au><au>YO MATSUO</au><au>SHOJI HISADA</au><au>WENGE CUI</au><au>ROBERT B. KARGBO</au><au>DAVID M. JENKINS</au><au>POLIVINA JOLICIA F. GAUUAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives</title><date>2018-05-31</date><risdate>2018</risdate><abstract>Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; heb
recordid cdi_epo_espacenet_IL222080B
source esp@cenet
title 6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T06%3A07%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JOEL%20R.%20WALKER&rft.date=2018-05-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL222080B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true